Genomma Lab Reports Q3 Sales Up 1.3%, Net Income Up 18.6%
Q3 2026 EBITDA margin was 21.0%; Latin America sales rose 12.2%, and Mexico returned to positive sell-out.
Genomma Lab Internacional reported that Q3 2026 net sales rose 1.3% and its EBITDA margin was 21.0%. Net income increased 18.6%. Sales in Latin America grew 12.2%, while Mexico returned to positive sell-out.